New Hepatitis C Point-of-Care Test Shows Promise Despite High Costs
University of Washington researchers find rapid test could improve treatment rates but may face implementation barriers due to reimbursement challenges.
Read MorePosted by CLP Edit Staff | Jan 5, 2026 | Molecular Diagnostics |
University of Washington researchers find rapid test could improve treatment rates but may face implementation barriers due to reimbursement challenges.
Read MorePosted by CLP Edit Staff | Jan 2, 2026 | Allergy & Autoimmune |
The test is being developed to differentiate between adenoviral conjunctivitis, herpetic keratitis, and allergic conjunctivitis at the point of care.
Read MorePosted by CLP Edit Staff | Dec 30, 2025 | Molecular Diagnostics |
The collaboration integrates AI-driven blood testing with a nationwide hepatology specialist network to reduce diagnostic delays.
Read MorePosted by CLP Edit Staff | Dec 29, 2025 | Histology |
The AI-powered pathology tool becomes the first AI-based drug development tool to receive FDA qualification, following earlier EMA approval.
Read MorePosted by CLP Edit Staff | Dec 29, 2025 | Analytical Software Systems |
The collaboration will provide urologists and oncologists nationwide access to AI-powered tools for non-muscle invasive bladder cancer management.
Read More